Announced

Charterhouse-backed Cooper acquired Laboratoires Diepharmex.

Synopsis

Cooper, a French pharmaceutical company backed by London-based private equity investment firm Charterhouse Capital Partners, acquired Laboratoires Diepharmex, a pharmaceutical company in Geneva, Switzerland. Financial terms were not disclosed. For Cooper, owned by Charterhouse since 2015, this new acquisition grants the opportunity to seize an iconic brand in hygiene and ear care.

Show Details & Financials

Did you work on this deal?

Claim Deal

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Claim Deal

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Charterhouse-backed Cooper acquired Laboratoires Diepharmex.